ZF

Zafgen

- NASDAQ:ZFGN
Last Updated 2020-05-29

LinkedIn Profile

Access Zafgen historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
nasdaq:zfgn 1466705 May 29th, 2020 12:00AM Zafgen, Inc. 2.2K 19.00 Open Biotechnology May 28th, 2020 10:58PM May 28th, 2020 10:58PM Zafgen (Nasdaq:ZFGN) is a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel therapies for patients affected by a range of complex metabolic diseases. The company has pioneered the study of MetAP2 inhibitors in both common and rare metabolic disorders, and its current disease areas of focus are type 2 diabetes, Prader-Willi syndrome and other rare and serious forms of obesity. Zafgen is well-capitalized and has assembled a team accomplished in bringing therapies to patients affected by metabolic disease. Open Obesity therapeutics, Orphan drug products, Cardiovascular and Metabolic Disease, Rare diseases, Prader-Willi Syndrome, Type 2 diabetes Open 3 Center Plaza, Suite 610 Boston MA US 02108 Zafgen Health Care Pharmaceuticals & Biotechnology
nasdaq:zfgn 1466705 May 28th, 2020 12:00AM Zafgen, Inc. 2.2K 19.00 Open Biotechnology May 28th, 2020 12:57PM May 28th, 2020 12:57PM Zafgen (Nasdaq:ZFGN) is a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel therapies for patients affected by a range of complex metabolic diseases. The company has pioneered the study of MetAP2 inhibitors in both common and rare metabolic disorders, and its current disease areas of focus are type 2 diabetes, Prader-Willi syndrome and other rare and serious forms of obesity. Zafgen is well-capitalized and has assembled a team accomplished in bringing therapies to patients affected by metabolic disease. Open Obesity therapeutics, Orphan drug products, Cardiovascular and Metabolic Disease, Rare diseases, Prader-Willi Syndrome, Type 2 diabetes Open 3 Center Plaza, Suite 610 Boston MA US 02108 Zafgen Health Care Pharmaceuticals & Biotechnology
nasdaq:zfgn 1466705 May 27th, 2020 12:00AM Zafgen, Inc. 2.2K 19.00 Open Biotechnology May 26th, 2020 10:59PM May 26th, 2020 10:59PM Zafgen (Nasdaq:ZFGN) is a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel therapies for patients affected by a range of complex metabolic diseases. The company has pioneered the study of MetAP2 inhibitors in both common and rare metabolic disorders, and its current disease areas of focus are type 2 diabetes, Prader-Willi syndrome and other rare and serious forms of obesity. Zafgen is well-capitalized and has assembled a team accomplished in bringing therapies to patients affected by metabolic disease. Open Obesity therapeutics, Orphan drug products, Cardiovascular and Metabolic Disease, Rare diseases, Prader-Willi Syndrome, Type 2 diabetes Open 3 Center Plaza, Suite 610 Boston MA US 02108 Zafgen Health Care Pharmaceuticals & Biotechnology
nasdaq:zfgn 1466705 May 26th, 2020 12:00AM Zafgen, Inc. 2.2K 19.00 Open Biotechnology May 26th, 2020 09:21AM May 26th, 2020 09:21AM Zafgen (Nasdaq:ZFGN) is a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel therapies for patients affected by a range of complex metabolic diseases. The company has pioneered the study of MetAP2 inhibitors in both common and rare metabolic disorders, and its current disease areas of focus are type 2 diabetes, Prader-Willi syndrome and other rare and serious forms of obesity. Zafgen is well-capitalized and has assembled a team accomplished in bringing therapies to patients affected by metabolic disease. Open Obesity therapeutics, Orphan drug products, Cardiovascular and Metabolic Disease, Rare diseases, Prader-Willi Syndrome, Type 2 diabetes Open 3 Center Plaza, Suite 610 Boston MA US 02108 Zafgen Health Care Pharmaceuticals & Biotechnology
nasdaq:zfgn 1466705 May 25th, 2020 12:00AM Zafgen, Inc. 2.2K 19.00 Open Biotechnology May 24th, 2020 11:04PM May 24th, 2020 11:04PM Zafgen (Nasdaq:ZFGN) is a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel therapies for patients affected by a range of complex metabolic diseases. The company has pioneered the study of MetAP2 inhibitors in both common and rare metabolic disorders, and its current disease areas of focus are type 2 diabetes, Prader-Willi syndrome and other rare and serious forms of obesity. Zafgen is well-capitalized and has assembled a team accomplished in bringing therapies to patients affected by metabolic disease. Open Obesity therapeutics, Orphan drug products, Cardiovascular and Metabolic Disease, Rare diseases, Prader-Willi Syndrome, Type 2 diabetes Open 3 Center Plaza, Suite 610 Boston MA US 02108 Zafgen Health Care Pharmaceuticals & Biotechnology
nasdaq:zfgn 1466705 May 24th, 2020 12:00AM Zafgen, Inc. 2.2K 19.00 Open Biotechnology May 23rd, 2020 10:58PM May 23rd, 2020 10:58PM Zafgen (Nasdaq:ZFGN) is a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel therapies for patients affected by a range of complex metabolic diseases. The company has pioneered the study of MetAP2 inhibitors in both common and rare metabolic disorders, and its current disease areas of focus are type 2 diabetes, Prader-Willi syndrome and other rare and serious forms of obesity. Zafgen is well-capitalized and has assembled a team accomplished in bringing therapies to patients affected by metabolic disease. Open Obesity therapeutics, Orphan drug products, Cardiovascular and Metabolic Disease, Rare diseases, Prader-Willi Syndrome, Type 2 diabetes Open 3 Center Plaza, Suite 610 Boston MA US 02108 Zafgen Health Care Pharmaceuticals & Biotechnology
nasdaq:zfgn 1466705 May 23rd, 2020 12:00AM Zafgen, Inc. 2.2K 19.00 Open Biotechnology May 23rd, 2020 01:50PM May 23rd, 2020 01:50PM Zafgen (Nasdaq:ZFGN) is a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel therapies for patients affected by a range of complex metabolic diseases. The company has pioneered the study of MetAP2 inhibitors in both common and rare metabolic disorders, and its current disease areas of focus are type 2 diabetes, Prader-Willi syndrome and other rare and serious forms of obesity. Zafgen is well-capitalized and has assembled a team accomplished in bringing therapies to patients affected by metabolic disease. Open Obesity therapeutics, Orphan drug products, Cardiovascular and Metabolic Disease, Rare diseases, Prader-Willi Syndrome, Type 2 diabetes Open 3 Center Plaza, Suite 610 Boston MA US 02108 Zafgen Health Care Pharmaceuticals & Biotechnology
nasdaq:zfgn 1466705 May 22nd, 2020 12:00AM Zafgen, Inc. 2.2K 19.00 Open Biotechnology May 21st, 2020 10:59PM May 21st, 2020 10:59PM Zafgen (Nasdaq:ZFGN) is a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel therapies for patients affected by a range of complex metabolic diseases. The company has pioneered the study of MetAP2 inhibitors in both common and rare metabolic disorders, and its current disease areas of focus are type 2 diabetes, Prader-Willi syndrome and other rare and serious forms of obesity. Zafgen is well-capitalized and has assembled a team accomplished in bringing therapies to patients affected by metabolic disease. Open Obesity therapeutics, Orphan drug products, Cardiovascular and Metabolic Disease, Rare diseases, Prader-Willi Syndrome, Type 2 diabetes Open 3 Center Plaza, Suite 610 Boston MA US 02108 Zafgen Health Care Pharmaceuticals & Biotechnology
nasdaq:zfgn 1466705 May 21st, 2020 12:00AM Zafgen, Inc. 2.2K 19.00 Open Biotechnology May 21st, 2020 11:48AM May 21st, 2020 11:48AM Zafgen (Nasdaq:ZFGN) is a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel therapies for patients affected by a range of complex metabolic diseases. The company has pioneered the study of MetAP2 inhibitors in both common and rare metabolic disorders, and its current disease areas of focus are type 2 diabetes, Prader-Willi syndrome and other rare and serious forms of obesity. Zafgen is well-capitalized and has assembled a team accomplished in bringing therapies to patients affected by metabolic disease. Open Obesity therapeutics, Orphan drug products, Cardiovascular and Metabolic Disease, Rare diseases, Prader-Willi Syndrome, Type 2 diabetes Open 3 Center Plaza, Suite 610 Boston MA US 02108 Zafgen Health Care Pharmaceuticals & Biotechnology
nasdaq:zfgn 1466705 May 20th, 2020 12:00AM Zafgen, Inc. 2.2K 19.00 Open Biotechnology May 20th, 2020 01:29PM May 20th, 2020 01:29PM Zafgen (Nasdaq:ZFGN) is a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel therapies for patients affected by a range of complex metabolic diseases. The company has pioneered the study of MetAP2 inhibitors in both common and rare metabolic disorders, and its current disease areas of focus are type 2 diabetes, Prader-Willi syndrome and other rare and serious forms of obesity. Zafgen is well-capitalized and has assembled a team accomplished in bringing therapies to patients affected by metabolic disease. Open Obesity therapeutics, Orphan drug products, Cardiovascular and Metabolic Disease, Rare diseases, Prader-Willi Syndrome, Type 2 diabetes Open 3 Center Plaza, Suite 610 Boston MA US 02108 Zafgen Health Care Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.